United States

Endo International PLC (ENDP.OQ)

ENDP.OQ on NASDAQ Stock Exchange Global Select Market

20 Oct 2016
Change (% chg)

-- (--)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low


Chart for ENDP.OQ


Endo International plc is a global specialty pharmaceutical company focused on developing, manufacturing, marketing and distributing branded and generic pharmaceutical products, as well as over-the-counter medications through its operating companies- Endo Pharmaceuticals, Par Pharmaceutical, Paladin Labs and SOMAR. The Company’s... (more)


Beta: 0.63
Market Cap(Mil.): $4,573.40
Shares Outstanding(Mil.): 222.77
Dividend: --
Yield (%): --


  ENDP.OQ Industry Sector
P/E (TTM): -- 36.52 36.36
EPS (TTM): -0.51 -- --
ROI: -0.43 14.42 13.86
ROE: -0.95 15.19 14.78

Endo International CEO steps down, Campanelli named successor

Endo International Plc said Chief Executive Rajiv De Silva had stepped down and would be replaced by generics division head Paul Campanelli, as the drugmaker grapples with a large debt load and mounting pressure on some of its drug prices.

Sep 23 2016

Endo International CEO steps down; Campanelli named successor

Sept 23 Drugmaker Endo International Plc said on Friday Chief Executive and President Rajiv De Silva had stepped down, and named Paul Campanelli as his successor.

Sep 23 2016

Highlights: Top U.S. hedge funds bet on Alphabet, Netflix and retailers

NEW YORK Former SAC executive Gabe Plotkin's Melvin Capital took a new position in streaming video service Netflix Inc, buying 950,000 shares and a call option for 1.45 million shares, according to regulatory filings on Monday. Melvin Capital also took a new position in Home Depot Inc, buying 475,000 shares. And Passport Capital added 3.3 million Yahoo Inc shares, upping its stake by 243 percent, filings show.

May 16 2016

Earnings vs. Estimates